FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386192485> ?p ?o ?g. }

• W4386192485 abstract "Task Force structure and summary of clinical evidence of 2022 ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease. CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; LM, left main; SYNTAX, Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery. a'Event' refers to the composite of death, myocardial infarction (according to Universal Definition of Myocardial Infarction if available, otherwise protocol defined) or stroke. In October 2021, the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) jointly agreed to establish a Task Force (TF) to review recommendations of the 2018 ESC/EACTS Guidelines on myocardial revascularization as they apply to patients with left main (LM) disease with low-to-intermediate SYNTAX score (0-32). This followed the withdrawal of support by the EACTS in 2019 for the recommendations about the management of LM disease of the previous guideline. The TF was asked to review all new relevant data since the 2018 guidelines including updated aggregated data from the four randomized trials comparing percutaneous coronary intervention (PCI) with drug-eluting stents vs. coronary artery bypass grafting (CABG) in patients with LM disease. This document represents a summary of the work of the TF; suggested updated recommendations for the choice of revascularization modality in patients undergoing myocardial revascularization for LM disease are included. In stable patients with an indication for revascularization for LM disease, with coronary anatomy suitable for both procedures and a low predicted surgical mortality, the TF concludes that both treatment options are clinically reasonable based on patient preference, available expertise, and local operator volumes. The suggested recommendations for revascularization with CABG are Class I, Level of Evidence A. The recommendations for PCI are Class IIa, Level of Evidence A. The TF recognized several important gaps in knowledge related to revascularization in patients with LM disease and recognizes that aggregated data from the four randomized trials were still only large enough to exclude large differences in mortality." @default.
• W4386192485 created "2023-08-27" @default.
• W4386192485 creator A5015518003 @default.
• W4386192485 creator A5016139987 @default.
• W4386192485 creator A5018896453 @default.
• W4386192485 creator A5027213857 @default.
• W4386192485 creator A5030250235 @default.
• W4386192485 creator A5033459729 @default.
• W4386192485 creator A5033558270 @default.
• W4386192485 creator A5041998767 @default.
• W4386192485 creator A5078886051 @default.
• W4386192485 creator A5078997813 @default.
• W4386192485 creator A5086795617 @default.
• W4386192485 creator A5087550320 @default.
• W4386192485 date "2023-08-01" @default.
• W4386192485 modified "2023-10-17" @default.
• W4386192485 title "2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG" @default.
• W4386192485 cites W1966585409 @default.
• W4386192485 cites W1970357164 @default.
• W4386192485 cites W1982375973 @default.
• W4386192485 cites W2038630181 @default.
• W4386192485 cites W2079974476 @default.
• W4386192485 cites W2089961600 @default.
• W4386192485 cites W2098674170 @default.
• W4386192485 cites W2137458934 @default.
• W4386192485 cites W2140991303 @default.
• W4386192485 cites W2144028400 @default.
• W4386192485 cites W2539688728 @default.
• W4386192485 cites W2556734079 @default.
• W4386192485 cites W2607400219 @default.
• W4386192485 cites W2786107187 @default.
• W4386192485 cites W2808359328 @default.
• W4386192485 cites W2889329974 @default.
• W4386192485 cites W2905645650 @default.
• W4386192485 cites W2916912835 @default.
• W4386192485 cites W2970357772 @default.
• W4386192485 cites W2975990972 @default.
• W4386192485 cites W2984919945 @default.
• W4386192485 cites W2994638107 @default.
• W4386192485 cites W3012388634 @default.
• W4386192485 cites W3013047924 @default.
• W4386192485 cites W3037639200 @default.
• W4386192485 cites W3089100520 @default.
• W4386192485 cites W3091306188 @default.
• W4386192485 cites W3091323543 @default.
• W4386192485 cites W3092190809 @default.
• W4386192485 cites W3092193456 @default.
• W4386192485 cites W3108176058 @default.
• W4386192485 cites W3162604415 @default.
• W4386192485 cites W3164824045 @default.
• W4386192485 cites W3178642823 @default.
• W4386192485 cites W3200488332 @default.
• W4386192485 cites W3206478736 @default.
• W4386192485 cites W3212504172 @default.
• W4386192485 cites W4205653014 @default.
• W4386192485 cites W4210431983 @default.
• W4386192485 cites W4210703658 @default.
• W4386192485 cites W4220697834 @default.
• W4386192485 doi "https://doi.org/10.1093/ejcts/ezad286" @default.
• W4386192485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37632766" @default.
• W4386192485 hasPublicationYear "2023" @default.
• W4386192485 type Work @default.
• W4386192485 citedByCount "0" @default.
• W4386192485 crossrefType "journal-article" @default.
• W4386192485 hasAuthorship W4386192485A5015518003 @default.
• W4386192485 hasAuthorship W4386192485A5016139987 @default.
• W4386192485 hasAuthorship W4386192485A5018896453 @default.
• W4386192485 hasAuthorship W4386192485A5027213857 @default.
• W4386192485 hasAuthorship W4386192485A5030250235 @default.
• W4386192485 hasAuthorship W4386192485A5033459729 @default.
• W4386192485 hasAuthorship W4386192485A5033558270 @default.
• W4386192485 hasAuthorship W4386192485A5041998767 @default.
• W4386192485 hasAuthorship W4386192485A5078886051 @default.
• W4386192485 hasAuthorship W4386192485A5078997813 @default.
• W4386192485 hasAuthorship W4386192485A5086795617 @default.
• W4386192485 hasAuthorship W4386192485A5087550320 @default.
• W4386192485 hasBestOaLocation W43861924851 @default.
• W4386192485 hasConcept C126322002 @default.
• W4386192485 hasConcept C142724271 @default.
• W4386192485 hasConcept C164705383 @default.
• W4386192485 hasConcept C168563851 @default.
• W4386192485 hasConcept C2778213512 @default.
• W4386192485 hasConcept C2779464278 @default.
• W4386192485 hasConcept C2780182762 @default.
• W4386192485 hasConcept C2780400711 @default.
• W4386192485 hasConcept C45393284 @default.
• W4386192485 hasConcept C500558357 @default.
• W4386192485 hasConcept C71924100 @default.
• W4386192485 hasConceptScore W4386192485C126322002 @default.
• W4386192485 hasConceptScore W4386192485C142724271 @default.
• W4386192485 hasConceptScore W4386192485C164705383 @default.
• W4386192485 hasConceptScore W4386192485C168563851 @default.
• W4386192485 hasConceptScore W4386192485C2778213512 @default.
• W4386192485 hasConceptScore W4386192485C2779464278 @default.
• W4386192485 hasConceptScore W4386192485C2780182762 @default.
• W4386192485 hasConceptScore W4386192485C2780400711 @default.
• W4386192485 hasConceptScore W4386192485C45393284 @default.
• W4386192485 hasConceptScore W4386192485C500558357 @default.
• W4386192485 hasConceptScore W4386192485C71924100 @default.
• W4386192485 hasIssue "2" @default.

• next